Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
	Feb. 15, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 20, 2023
Stockholders’ Equity (Details) [Line Items]
Shares forfeited (in Shares)		0	2,190
Share-based compensation expense		$ 3.1	$ 1.5
Unamortized share-based compensation expense		$ 4.4
Weighted average term		1 year 9 months 18 days
Weighted average sales price per share		$ 15.9	$ 15.78
Offering cost				$ 75.0
Gross proceeds percentage		3.00%
At-the-Market Offering Program [Member]
Stockholders’ Equity (Details) [Line Items]
Net proceeds from direct offering		$ 38.4	$ 1.2
Sold an aggregate shares (in Shares)		2,489,290	79,862
2021 Equity Incentive Plan [Member]
Stockholders’ Equity (Details) [Line Items]
Stock issued during period, restricted stock award grants (in Shares)		187,335	323,452
Issued and outstanding shares percentage		8.50%	8.50%
2021 Equity Incentive Plan [Member] | Employees of Manager [Member]
Stockholders’ Equity (Details) [Line Items]
Stock issued during period, restricted stock award grants (in Shares)		163,280
2021 Equity Incentive Plan [Member] | Employees of Manager [Member] | Resticted Stock Award [Member]
Stockholders’ Equity (Details) [Line Items]
Vesting period		3 years
2021 Equity Incentive Plan [Member] | Independent Member of Board [Member]
Stockholders’ Equity (Details) [Line Items]
Stock issued during period, restricted stock award grants (in Shares)		24,055
2021 Equity Incentive Plan [Member] | Independent Member of Board [Member] | Resticted Stock Award [Member]
Stockholders’ Equity (Details) [Line Items]
Vesting period		1 year
Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares (in Shares)	395,779
Price per share (in Dollars per share)	$ 15.16
Net proceeds from direct offering	$ 6.0